It has been demonstrated using matched pairs of ER-positive breast cancers that the level of MCL1 alteration in primary and metastatic disease is comparable, so it remains to be determined whether MCL-1 expression is important for metastatic dissemination or if increases in MCL-1 protein occur at secondary tumor sites [46]. The gene discussed is MCL1; the disease is neoplasm.